NPS Pharmaceuticals ( NPSP ) has bought back the none-North American rights to two drugs from Takeda for $50M in shares and possible milestone payments, giving NPS with full global rights to the treatments. The drugs are Revestive (Gattex in the U.S.), a medicine for short bowel syndrome, and ... Oppenheimer initiates NPS Pharmaceuticals ( NPSP ) at Outperform with a price target of $18. "There are no direct competitors for Gattex and Natpara," writes analyst Boris Peaker, adding that investors shouldn't be wary of "owning a launch name" in this case because the company's "first-in-class ... NPS Pharmaceuticals ( NPSP ): Q4 EPS of -$0.14 misses by $0.05 . Revenue of $27.2M misses by $1.73M . ( PR ) Post your comment! NPS Pharmaceuticals ( NPSP 14.3% ) pops today after it says the FDA has released the briefing documents ahead of its October 16 Advisory Committee meeting for NPSP 's experimental drug Gattex, which is being developed for the treatment of adults with short bowel syndrome. The overall comments ... NPS Pharmaceuticals ( NPSP +04% ) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex will be available in Q113. Post your comment! NPS Pharmaceuticals, Inc. ( NPSP ) Q1 2013 Earnings Call May 9, 2013 8:30 AM ET Executives Susan Mesco – Senior Director, IR Francois Nader – President and CEO Eric Pauwels – SVP and Chief Commercial Officer Luke Beshar – EVP and CFO Roger Garceau – SVP and Chief Medical Officer Analysts Yuan Yang ... NPS Pharmaceuticals Inc. ( NPSP ) NPS Pharmaceuticals and Takeda Revise Agreements Conference Call March 19, 2013 8:30 AM ET Executives Susan Mesco – Corporate Communications Francois Nader – President and CEO Eric Pauwels – SVP and Chief Commercial Officer Luke Beshar – EVP and CFO Analysts Alan ... NPS Pharmaceuticals, Inc. ( NPSP ) Q4 2012 Earnings Call February 21, 2013 4:30 PM ET Executives Susan Mesco – Senior Director, IR and Corporate Communications Francois Nader – President and CEO Eric Pauwels – SVP and Chief Commercial Officer Luke Beshar – EVP and CFO Analysts Salveen Richter – ... NPS Pharmaceuticals, Inc. ( NPSP ) 31st Annual J.P. Morgan Healthcare Conference Call January 09, 2013, 12:00 pm ET Executives Francois Nader - President & CEO Analysts Geoff Meacham - J.P. Morgan Presentation Geoff Meacham - J.P. Morgan Good morning and welcome to day three of the 31 st Annual ... By Codespeed : In 2006, NPS Pharmaceuticals ( NPSP ) had found itself in big mess after its stock price dropped 37% on a single day after the FDA asked the company to run additional clinical trials on its upcoming drug for Osteoporosis. Cash reserves were about to dry up as more than $190 million ...